Site icon Biweekly newsletter of the International Cytokine & Interferon Society

Clinical Trials

Clinical Trials, contributed by Howard A. Young

Clinical Trials, contributed by Howard A. Young

Clinical Trials of interest to cytokine & interferon researchers.

Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCT
ClinicalTrials.gov ID NCT06130579
Sponsor: Peking University People’s Hospital
Information provided by Xiao-Jun Huang, Peking University People’s Hospital (Responsible Party)
Last Update Posted 2024-03-21

MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera (MITHRIDATE)
ClinicalTrials.gov ID NCT04116502
Sponsor: University of Birmingham
Information provided by University of Birmingham (Responsible Party)
Last Update Posted 2024-05-10

Effect of Low-dose Interferon-alfa2a on Peri-operative Immune Suppression (IPOS)
ClinicalTrials.gov ID NCT04798612
Sponsor: Zealand University Hospital
Information provided by Zealand University Hospital (Responsible Party)
Last Update Posted 2023-08-18

Exit mobile version